Cargando…

Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool

Galactosidases are widespread enzymes that are used for manifold applications, including production of prebiotics, biosynthesis of different transgalactosylated products, improving lactose tolerance and in various analytical approaches. The nature of these applications often require galactosidases t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragosits, Martin, Pflügl, Stefan, Kurz, Simone, Razzazi-Fazeli, Ebrahim, Wilson, Iain B. H., Rendic, Dubravko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973953/
https://www.ncbi.nlm.nih.gov/pubmed/24037406
http://dx.doi.org/10.1007/s00253-013-5192-3
_version_ 1782479399958872064
author Dragosits, Martin
Pflügl, Stefan
Kurz, Simone
Razzazi-Fazeli, Ebrahim
Wilson, Iain B. H.
Rendic, Dubravko
author_facet Dragosits, Martin
Pflügl, Stefan
Kurz, Simone
Razzazi-Fazeli, Ebrahim
Wilson, Iain B. H.
Rendic, Dubravko
author_sort Dragosits, Martin
collection PubMed
description Galactosidases are widespread enzymes that are used for manifold applications, including production of prebiotics, biosynthesis of different transgalactosylated products, improving lactose tolerance and in various analytical approaches. The nature of these applications often require galactosidases to be present in a purified form with clearly defined properties, including precisely determined substrate specificities, low sensitivity to inhibitors, and high efficiency and stability under distinct conditions. In this study, we present the recombinant expression and purification of two previously uncharacterized β-galactosidases from Aspergillus nidulans as well as one β-galactosidase from Aspergillus niger. All enzymes were active toward p-nitrophenyl-β-d-galactopyranoside as substrate and displayed similar temperature and pH optima. The purified recombinant galactosidases digested various complex substrates containing terminal galactose β-1,4 linked to either N-acetylglucosamine or fucose, such as N-glycans derived from bovine fibrin and Caenorhabditis elegans. In our comparative study of the recombinant galactosidases with the commercially available galactosidase from Aspergillus oryzae, all enzymes also displayed various degrees of activity toward complex oligosaccharides containing β-1,3-linked terminal galactose residues. All recombinant enzymes were found to be robust in the presence of various organic solvents, temperature variations, and freeze/thaw cycles and were also tested for their ability to synthesize galactooligosaccharides. Furthermore, the use of fermentors considerably increased the yield of recombinant galactosidases. Taken together, we demonstrate that purified recombinant galactosidases from A. niger and from A. nidulans are suitable for various glycobiological and biotechnological applications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00253-013-5192-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3973953
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-39739532014-04-07 Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool Dragosits, Martin Pflügl, Stefan Kurz, Simone Razzazi-Fazeli, Ebrahim Wilson, Iain B. H. Rendic, Dubravko Appl Microbiol Biotechnol Biotechnologically Relevant Enzymes and Proteins Galactosidases are widespread enzymes that are used for manifold applications, including production of prebiotics, biosynthesis of different transgalactosylated products, improving lactose tolerance and in various analytical approaches. The nature of these applications often require galactosidases to be present in a purified form with clearly defined properties, including precisely determined substrate specificities, low sensitivity to inhibitors, and high efficiency and stability under distinct conditions. In this study, we present the recombinant expression and purification of two previously uncharacterized β-galactosidases from Aspergillus nidulans as well as one β-galactosidase from Aspergillus niger. All enzymes were active toward p-nitrophenyl-β-d-galactopyranoside as substrate and displayed similar temperature and pH optima. The purified recombinant galactosidases digested various complex substrates containing terminal galactose β-1,4 linked to either N-acetylglucosamine or fucose, such as N-glycans derived from bovine fibrin and Caenorhabditis elegans. In our comparative study of the recombinant galactosidases with the commercially available galactosidase from Aspergillus oryzae, all enzymes also displayed various degrees of activity toward complex oligosaccharides containing β-1,3-linked terminal galactose residues. All recombinant enzymes were found to be robust in the presence of various organic solvents, temperature variations, and freeze/thaw cycles and were also tested for their ability to synthesize galactooligosaccharides. Furthermore, the use of fermentors considerably increased the yield of recombinant galactosidases. Taken together, we demonstrate that purified recombinant galactosidases from A. niger and from A. nidulans are suitable for various glycobiological and biotechnological applications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00253-013-5192-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2013-09-15 2014 /pmc/articles/PMC3973953/ /pubmed/24037406 http://dx.doi.org/10.1007/s00253-013-5192-3 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Biotechnologically Relevant Enzymes and Proteins
Dragosits, Martin
Pflügl, Stefan
Kurz, Simone
Razzazi-Fazeli, Ebrahim
Wilson, Iain B. H.
Rendic, Dubravko
Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
title Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
title_full Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
title_fullStr Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
title_full_unstemmed Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
title_short Recombinant Aspergillus β-galactosidases as a robust glycomic and biotechnological tool
title_sort recombinant aspergillus β-galactosidases as a robust glycomic and biotechnological tool
topic Biotechnologically Relevant Enzymes and Proteins
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973953/
https://www.ncbi.nlm.nih.gov/pubmed/24037406
http://dx.doi.org/10.1007/s00253-013-5192-3
work_keys_str_mv AT dragositsmartin recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool
AT pfluglstefan recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool
AT kurzsimone recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool
AT razzazifazeliebrahim recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool
AT wilsoniainbh recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool
AT rendicdubravko recombinantaspergillusbgalactosidasesasarobustglycomicandbiotechnologicaltool